Company Norda ASA Oslo Bors
Equities
NORD
NO0010285190
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 13-04-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-06-19 | |
Chairman | 52 | 12-06-20 | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,148,808 | 322,428 ( 6.262 %) | 178,077 ( 3.459 %) | 6.262 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
NYKODE THERAPEUTICS 2.45% | 7,996,755 | 2.45% | 11,110,292 $ |
DEEP VALUE DRILLER 1.66% | 1,435,284 | 1.66% | 3,525,273 $ |
SAGA PURE ASA 0.45% | 2,185,611 | 0.45% | 259,301 $ |
BERGENBIO ASA 0.17% | 4,529,064 | 0.17% | 81,433 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-17.60% | 11.52B | |
+39.11% | 3.27B | |
-20.67% | 2.02B | |
-29.30% | 1.44B | |
+11.45% | 1.01B | |
-6.33% | 719M | |
-30.75% | 418M | |
-51.02% | 339M | |
-2.58% | 284M |